Cite
A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A.
MLA
Ha, Nina, et al. “A Novel Histone Deacetylase 6 Inhibitor Improves Myelination of Schwann Cells in a Model of Charcot-Marie-Tooth Disease Type 1A.” British Journal of Pharmacology, vol. 177, no. 22, Nov. 2020, pp. 5096–113. EBSCOhost, https://doi.org/10.1111/bph.15231.
APA
Ha, N., Choi, Y. I., Jung, N., Song, J. Y., Bae, D. K., Kim, M. C., Lee, Y. J., Song, H., Kwak, G., Jeong, S., Park, S., Nam, S. H., Jung, S., Choi, B., Jung, S.-C., & Choi, B.-O. (2020). A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A. British Journal of Pharmacology, 177(22), 5096–5113. https://doi.org/10.1111/bph.15231
Chicago
Ha, Nina, Young Il Choi, Namhee Jung, Ju Young Song, Dae Kwon Bae, Min Cheol Kim, Yong Jae Lee, et al. 2020. “A Novel Histone Deacetylase 6 Inhibitor Improves Myelination of Schwann Cells in a Model of Charcot-Marie-Tooth Disease Type 1A.” British Journal of Pharmacology 177 (22): 5096–5113. doi:10.1111/bph.15231.